Antonio Ciaramella

Title: Antonio Ciaramella: Innovator in Immunoregulator Compounds

Introduction

Antonio Ciaramella is a notable inventor based in Genazzano, Italy. He has made significant contributions to the field of immunology through his innovative work on sphingosine derivative compounds. With a total of 2 patents, Ciaramella's inventions focus on enhancing the microbicidal activity of macrophages, which plays a crucial role in the immune response against bacterial infections.

Latest Patents

Ciaramella's latest patents revolve around immunoregulator compounds, specifically D-erythro-sphingosine 1-phosphate (S1P). These compounds are designed to be used as immunomodulators in the treatment of infections caused by bacteria. The unique characteristic of these compounds is their ability to stimulate macrophagic Phospholipase D (PLD). Furthermore, the patents include pharmaceutical compositions that incorporate these sphingosine derivative compounds, along with diagnostic methods for their preparation. The inventions also outline methods for inducing or restoring the microbicidal activity of macrophages in vitro, which is essential for monitoring the efficiency of phagocytosis and degradation processes.

Career Highlights

Antonio Ciaramella is affiliated with the Università degli Studi di Roma “Tor Vergata,” where he conducts his research and development work. His academic background and ongoing research contribute to the advancement of immunological treatments and therapies.

Collaborations

Ciaramella has collaborated with notable colleagues such as Maurizio Fraziano and Sanjay Kumar Garg. These collaborations enhance the scope and impact of his research in the field of immunology.

Conclusion

Antonio Ciaramella is a distinguished inventor whose work on immunoregulator compounds has the potential to significantly improve treatments for bacterial infections. His contributions to the field of immunology are noteworthy and continue to influence ongoing research and development.